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Objectives'. This study sought to analyze the outcomes of 
revascularization procedures in the treatment of aliograft coro- 
nary disease. 
Background. Mlograft vasculopathy is the main factor limiting 
survival of heart ransplant recipients. Because no medical ther- 
apy prevents allograft atherosclerosis, and retransplantation is 
associated with suboptimal iograft survival, palliative coronary 
revascularization has been attempted. 
Methods. Thirteen medical centers retrospectively analyzed 
their complete xperience with percutaneous transluminal corn- 
nary angioplasty, directional coronary atherectomy and coronary 
bypass graft surgery in allograft coronary disease. 
Results. Sixty-six patients underwent coronary angioplasty. 
Angiographic success (<50% residual stenosis) occurred in 153 
(94%) of 162 lesions. Forty patients (61%) are alive without 
retransplantation at 19 -+ 14 (mean -+ SD) months after angio- 
plasty. The consequences of failed revascularization were severe. 
Two patients ustained periprocedural myocardial infarction and 
died. Angiographic restenosis occurred in 42 (55%) of 76 lesions at 
8 -+ 5 months after angioplasty. Angiographic distal arteriopathy 
adversely affected allograft survival. Eleven patients underwent 
directional coronary atherectomy. Angiographic success occurred 
in 9 (82%) of 11 lesions. Two periprocedural deaths occurred. 
Nine patients are alive without ransplantation at7 -+ 4 months 
after atherectomy. Bypass graft surgery was performed in 12 
patients. Four patients died perioperatively. Seven patients are 
alive without retransplantation at 9 -+ 7 months after operation. 
Conclusions. Coronary revascularization may be an effective 
palliative therapy in suitable cardiac transplant recipients. An- 
gioplasty has an acceptable survival in patients without angio- 
graphic distal arteriopathy. Because few patients underwent 
atherectomy and coronary bypass urgery, assessment of these 
procedures i  limited. Angiographic distal arteriopathy is associ- 
ated with decreased allograft survival in patients requiring revas- 
cularization. 
(J Am CoU Cardiol 1995;26:120-8) 
Accelerated coronary artery.' disease is the leading cause of 
death in heart transplant recipients by the first year after 
transplantation (1-5). The prevalence of allograft coronary 
artery disease is -1% to 18% by 1 year and 40% to 50% by 5 
years after transplantation (6,7). Clinical manifestations of 
ischemia in heart ransplant recipients include congestive heart 
failure, ventricular arrhythmias, udden death and myocardial 
infarction (8); angina pectoris (8-12) may infrequently occur. 
Coronary angiography is currently the standard method for 
diagnosing allograft coronary artery disease because noninva- 
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sive modalities, uch as exercise thallium scintigraphy, rest and 
exercise radionuclide cineangiography, echocardiography and 
Holter monitoring, are insensitive (13,14). Angiographically, 
patients with allograft arteriopathy have a mixture of diffuse 
arterial narrowing of mid- and distal vessels with distal vessel 
obliteration and, less frequently, discrete proximal stenoses 
(15). 
At present there is no proven therapy for the prevention or 
retardation of allograft coronary artery disease, although cal- 
cium channel blocking agents may slow its initial development 
(16). Repeat cardiac transplantation has been performed, but 
survival after retransplantation is shorter than after initial 
transplantation (17,18). In view of the limited donor supply 
(19) a number of centers no longer ecommend retransplan- 
tation (5). 
Coronary artery revascularization in heart ransplant recip- 
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ients, utilizing percutaneous transluminal coronary angioplasty 
(12,20-22), directional coronary atherectomy (23-25) and 
coronary artery bypass graft surgery (26-28), has been per- 
formed in selected patients as palliative therapy to decrease 
ischemia-related morbidity and mortality. Because no single 
institution has performed many revascularization procedures 
in cardiac transplant recipients, representatives from several 
transplant centers agreed that a collaborative effort should be 
made to describe their complete xperience with coronary 
revascularization procedures incardiac transplant recipients to 
determine the outcome of revascularization therapy for al- 
lograft coronary artery disease. 
Methods 
Patients. Representatives of 13 medical centers retrospec- 
tively analyzed the medical records and cineangiograms of all 
cardiac transplant recipients who were treated with balloon 
angioplasty, directional coronary atherectomy or coronary 
artery bypass urgery. The investigators documented the clin- 
ical characteristics, angiographic features, procedural results 
and late outcome after coronary revascularization  a data 
form that was collaboratively developed before the study. Case 
selection for revascularization a d the mode of revasculariza- 
tion were decided by the individual centers. In most instances 
targets for revascularization were limited to those with a high 
probability of procedural success. 
Eleven of these institutions previously reported the success- 
ful application of balloon angioplas b, in 35 transplant recipi- 
ents (12). The present report highlights the long-term follow- 
up of an extended number of patients treated with coronary, 
angioplasty and describes these centers' preliminary experi- 
ence with directional atherectomy and coronary artery bypass 
surgery. 
Statistical methods and measurements. Mean values and 
standard eviations of the mean were calculated and expressed 
as mean value _+ SD. The Student test was performed to 
determine significant differences between mean values. Chi- 
square analysis and the Fisher exact est were used to ascertain 
the relation between distal arteriopathy and late outcome. 
Kaplan-Meier survival curves were constructed to estimate 
survival after revascularization procedures in cardiac trans- 
plant recipients. Differences between curves were determined 
by the log-rank test. A two-sided alpha level <0.05 was 
considered statistically significant. 
Definitions. The determination of angiographic stenosis 
was made by visual estimate. Angiographic success of an 
angioplasty or atherectomy procedure was defined as a post- 
procedural lumen diameter stenosis -<50%. Restenosis was 
defined as return of ->50% diameter stenosis. A primary 
revascularization procedure that was performed in two stages 
was considered one revascularization procedure. Angiographic 
distal arteriopathy, determined qualitatively, was defined as the 
presence of types A (discrete, tubular or multiple stenoses), B
(diffuse concentric narrowing) or C (diseased, diffusely irreg- 
Table I. Number and Location of Lesions Treated With 
Corona~ Angioplasty* 
Proximal LAD 23 
Mid-LAD 32 
Distal LAD 9 
First diagonal 11 
Second diagonal 2 
Proximal Cx 11 
Distal Cx 7 
First obtuse marginal 19 
Second obtuse marginal 8 
Third obtuse marginal 2 
Proximal RCA 9 
Mid-RCA 6 
Distal RCA 11 
Acute marginal 1 
Posterior descending 7 
First postcrolateral 1 
Second posterolateral 2 
Posterolateral segment 1 
Total 162 
*For corona~ artery surgery, classification, see Principal Investigators of 
CASS and Associates: National Heart, Lung, and Blood Institute Coronary 
Artery Surger~ Study. Circulation 1981;83 Suppl l:I-1-81. Cx - circumflex 
coronary' artery: LAD = left anterior descending coronary artery; RCA - right 
coronary artery 
ular, often nontapered) lesions of tertiary vessels, as defined by 
Gao et al. (15). 
Allograft survival was defined as the absence of retransplan- 
tation or death. 
Results 
Coronaryangioplasty. Clinicalcharacteristics. Of3,710pa- 
tients who underwent cardiac transplantation performed at the 
13 collaborating centers from January 1968 until November 
1991, 66 underwent balloon angioplasty (60 men, 6 women; 
mean [_+SD] age 50 _+ 11 years, range 18 to 76). The 
indications for cardiac transplantation were idiopathic car- 
diomyopathy in 36 patients, coronary artery disease with 
myopathy in29 and valvular heart disease in 1. The mean time 
from cardiac transplantation to the initial coronary angioplasty 
procedure was 47 - 28 months. 
Ninety-seven angioplasty procedures were performed; these 
included 31 repeat angioplasty procedures. The primary indi- 
cation for each procedure was angiographic coronary artery 
disease in 45 patients, noninvasive evidence of ischemia in 22, 
symptomatic ischemia in 13, worsening congestive heart failure 
in 8, rapidly progressive coronary artery disease in 7 and 
decreasing ventricular function in 2. Fifty-nine procedures 
(61%) were single-vessel angioplasty; 38 (39%) were multives- 
sel revascularization. 
Angiographic haracteristics. There were 138 de novo and 
24 restenotic lesions, comprising a total of 162 lesions, treated 
with coronary angioplasty. Table 1 indicates the locations of 
the dilated lesions. Twelve total occlusions and six subtotal 
(99% stenosis) occlusions were attempted. Distal arteriopathy 
was visible on the preprocedural ngiogram in 39 patients. 
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Table 2. Survival Outcome of Coronary Angioplasty in 66 
Transplant Recipients 
Survivors* 40 (61%) 
Death <6 mo after angioplasty 9 (14%) 
In-hospital death 2 (3%) 
Death >6 mo after angioplasty 10 (15%) 
Retransplantation (8 pts) 
Alive 5 (7%) 
*Alive without retransplantation. Data presented are number (%) of pa- 
tients (pts). 
Data regarding distal arteriopathy were unavailable for five 
patients. 
Angiographic results. Angiographic success was achieved in 
153 (94%) of 162 lesions. The mean preangioplasty stenosis 
was 83% _+ 11%; the mean postprocedural stenosis was 27% _+ 
19% (p = 0.0001). The reasons for the lack of success in the 
nine unsuccessful angioplasty attempts were inability to cross a 
total occlusion in five cases, failure to traverse a lesion with a 
guide wire in two and inability to attain <-50% residual stenosis 
in two. 
Figure 1. Actuarial survival in cardiac transplant recipients treated 
with coronary angioplasty. 
Complications. One patient developed a myocardial infarc- 
tion and died 6 h after angioplasty. A second patient sustained 
a left main coronary dissection by an Amplatz left coronary 
guiding catheter; this resulted in myocardial infarction and 
subsequent death 1 week after angioplasty. There were four 
groin hematomas. Thus, vascular complications were not more 
frequent or severe despite the use of chronic steroid immuno- 
suppression i  most patients. There was one transient exacer- 
bation of renal insufficiency. 
Late outcome. Forty (61%) of the 66 patients are alive 
without retransplantation at a mean of 19 + 14 months after 
coronary angioplasty (Table 2). Eight patients underwent 
retransplantation at a mean of 20 +_ 19 months after the initial 
angioplasty procedure, five of whom remain alive. Three 
patients died at 3 weeks, 4 months and 10 months after repeat 
transplantation, respectively. The actuarial survival of patients 
treated with angioplasty is depicted in Figure 1. Clinical 
follow-up information was available for all of the patients. 
Angiographic follow-up was obtained in 63 of the 97 (65%) 
procedures. Restenosis was present in 42 of 76 lesions (55%) at 
a mean of 8 _+ 5 months postangioplasty (range 2 to 19 
months). 
Nineteen patients underwent 31 repeat angioplasty proce- 
dures for 24 restenoses and 30 new lesions. The angiographic 
success rate was 54 (100%) of 54 lesions. Four patients 
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underwent subsequent directional coronary atherectomy pro- 
cedures at a mean of 7 _+ 4 months after angioplasty. Four 
patients underwent coronary artery bypass urgery at a mean 
of 10 _+ 5 months after angioplasty. 
Distal arteriopathy. In patients undergoing balloon angio- 
plasty there was a significantly higher mortality in patients with 
distal arteriopathy on the preangioplasty angiogram than in 
those without distal arteriopathy. Twenty-two f 39 patients 
(56%) with angiographic distal arteriopathy had subsequently 
died or underwent retransplantation compared with 4 of 22 
patients (18%) who had no angiographic distal arteriopathy. 
Figure 2 highlights the significant deleterious effect of distal 
arteriopathy on allograft survival in patients undergoing coro- 
nary angioplasty (p < 0.001). 
Furthermore, 11 (65%) of 17 surviving patients with distal 
arteriopathy required a subsequent revascularization proce- 
dure compared with 3 (17%) of 18 without distal arteriopathy. 
There was no significant association of the duration from 
transplantation to initial angioplasty, development of resteno- 
sis or indication for cardiac transplantation with survival. 
Directional coronary atherectomy. Clinical characteristics. 
Eleven cardiac transplant recipients underwent 11 single-vessel 
atherectomy procedures at 52 _+ 14 months after transplanta- 
tion. The primary indication for atherectomy was angiographic 
coronary artery disease in seven patients, worsening congestive 
Figure 2. Allograft survival after coronary angioplasty: effect of distal 
arteriopathy (DA). 
heart failure in two, symptomatic ischemia in one and progres- 
sive coronary artery disease in one. The lesions were located in 
the left anterior descending coronary artery system in seven 
patients (proximal in two, mid in three, distal in one; first 
diagonal in one), the circumflex artery system in three (prox- 
imal in two; first obtuse marginal in one) and the proximal 
right coronary artery in one. Ten lesions were de novo; one was 
restenotic. 
Four patients underwent coronary angioplasty before 
atherectomy, and two underwent atherectomy before angio- 
plasty. One patient underwent atherectomy for one lesion and 
angioplasty for a different lesion during the same procedure. 
These patients are analyzed in both the atherectomy and 
angioplasty groups in the present study. 
Early outcome. Angiographic success was achieved in 9 
(82%) of 11 lesions. The mean preatherectomy stenosis was 
91% _+ 5%; the mean postatherectomy stenosis was 34% _+ 
35% (p = 0.0003). 
There were two unsuccessful atherectomy procedures 
that resulted in patient death. One death resulted from left 
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Table 3. Corona U Artery Bypass Surgery in Cardiac 
Transplant Recipients 
No. of bypass grafts/procedure* 
One 4 
Two 4 
Three 4 
Conduit 
Internal mammary, arte U 6 
Saphenous vein 18 
*Total of 24 bypass grafts in 12 procedures. 
main coronary dissection. The second patient had acute 
thrombotic closure, was taken for emergent coronary bypass 
surgery in cardiogenic shock and died of pump failure 2 clays 
later. 
Late outcome. The nine patients with successful atherec- 
tomy procedures had a mean clinical follow-up of 7 +_ 4 
months. One patient required subsequent angioplasty proce- 
dures at 1, 6 and 12 months after atherectomy for restenoses. 
Another patient underwent angioplasty 2 months after 
atherectomy for a new lesion. 
Coronary artery bypass graft surgery, Clinical characteris- 
tics. Elective coronary artery bypass graft surgery was per- 
formed in 12 patients at 57 +_ 20 months after cardiac 
transplantation. Four patients had previous angioplasty for 
allograft coronary artery disease. 
The primary indication for bypass urgery was angiographic 
coronary artery disease in five patients, symptomatic ischemia 
in two, rapidly progressive coronary artery disease in two and 
worsening congestive heart failure in one. In two patients the 
primary reason for cardiac surgery was valvular heart disease: 
one had severe aortic insufficiency; the other had severe 
tricuspid regurgitation with biventricular heart failure. These 
patients underwent concomitant single-vessel bypass urgery 
for angiographic coronary artery disease. The mean left ven- 
tricular ejection fraction before bypass surgery by angio- 
graphic, radionuclide or echocardiographic techniques was 
48% _+ 11% in the nine patients in whom left ventricular 
systolic function was determined. 
Table 3 indicates the number of bypass grafts and the types 
of conduits utilized in the 12 coronary artery bypass opera- 
tions. 
Early outcome. Eight (67%) of 12 patients had successful 
operations and survived beyond hospital discharge. Four pa- 
tients (33%) died in-hospital; death was attributed to a com- 
bination of pump failure and bleeding in two patients, pump 
failure in one and bleeding in one. None of them had 
coexistent valvular heart disease. 
The effect of the presence of distal coronary artery disease 
detected on the angiogram before bypass urgery was exam- 
ined. Four (80%) of the five patients with angiographic distal 
arteriopathy died versus one (14%) of seven patients without 
distal arteriopathy (p = 0.07). 
Late outcome. The eight patients discharged from the 
hospital have had a mean clinical follow-up of 9 _+ 7 months, 
One patient died suddenly 2 months after bypass surgery; 
autopsy revealed diffuse atherosclerosis. One patient devel- 
oped angina 1 year after bypass urgery. Angiography demon- 
strated patency of two bypass grafts but occlusion of a saphe- 
nous vein graft to an obtuse marginal artery. An intracoronary 
stent was placed in the native circumflex artery, which relieved 
the angina during a 3-month follow-up period. 
Factors influencing outcome of revascularization proce- 
dures. Significance of distal arteriopathy. In the present study 
79 cardiac transplant recipients underwent revascularization 
procedures. This includes 10 patients who had several modes 
of revascularization: 4 had balloon angioplasty before direc- 
tional atherectomy; 4 had angioplasty before bypass urgery; 
and 2 had atherectomy before angioplasty. Subsequent to 
coronary revascularization, 21 patients died, and 5 underwent 
retransplantation a d remained alive. Figure 3 displays al- 
lograft survival of all patients undergoing coronary revascular- 
ization procedures. 
Several factors that may have influenced the long-term 
outcome of transplant recipients treated with coronary revas- 
cularization were analyzed. These included the angiographic 
presence of distal arteriopathy before the initial revasculari- 
zation procedure, time from transplantation to the initial 
revascularization procedure and indication for heart trans- 
plantation. Each patient who had multiple revascularization 
procedures (e.g., angioplasty and subsequent angioplasty, 
atherectomy or bypass surgery) was analyzed by the initial 
revascularization procedure only. The significant detrimental 
influence of distal arteriopathy onallograft survival (p = 0.005) 
is represented in Figure 4. In contrast, time from transplanta- 
tion to the initial revascularization procedure and the indica- 
tion for cardiac transplantation did not significantly affect 
allograft survival. 
Discuss ion  
Percutaneous coronary revascularization. The main objec- 
tive of coronary revascularization after heart ransplantation is 
to reduce ischemic morbidity and mortality. The current study 
indicates that coronary angioplasty in selected patients has an 
immediate success rate comparable to that for routine angio- 
plasty (29). Angioplasty may be applied successfully tomidves- 
sel and selected iscrete distal vessel stenoses as well as to total 
occlusions. Because of the rate of progression of allograft 
coronary artery disease, many patients require coronary revas- 
cularization of new lesions and restenoses during short-term 
follow-up. Restenoses are effectively treated by repeat angio- 
plasty, although other modalities of treatment may be consid- 
ered. The present sample size was insufficient to compare the 
rates of postangioplasty restenosis between ative and allograft 
coronary artery disease. 
Does angioplasty improve long-term adverse outcomes in 
cardiac transplant recipients with severe epicardial stenoses? 
Reports from Stanford (30) indicate that transplant recipients 
with 70% stenosis in a primary vessel had a 46%, 13% and 13% 
actuarial survival rate at 1, 2 and 5 years, respectively. Of 
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patients with ->50% stenosis, 48% had an ischemic event 
(myocardial infarction, congestive heart failure, sudden death 
and retransplantation) within 4 years of detection of allograft 
coronary artery disease (31). Because the extent of allograft 
arteriopathy in the Stanford and current study's patient pop- 
ulations differ, a fair comparison of the long-term outcomes 
cannot be made. A prospective, controlled study will be 
necessary to determine whether angioplasty improves the late 
outcome of patients with allograft coronary artery disease. 
The experience with directional coronary atherectomy in 
the treatment of allograft coronary artery disease is limited. 
These preliminary data suggest hat in selected patients 
athereetomy may be performed successfully. However, the 
small patient cohort makes it ditficult to compare rates of 
procedural success and complications with directional atheree- 
tomy of nontransplant atherosclerosis. 
The low incidence of procedural complications with percu- 
taneous coronary interventions in the present series may be 
attributed to careful patient selection with limitation of revas- 
cularization in most cases to discrete stenoses with a high 
likelihood of procedural success. Acute complications of per- 
cutaneous revascularization i transplant coronary disease 
appear greater in severity than complications of angioplasty 
and atherectomy in nontransplant a herosclerosis (32). An 
important consideration i  percutaneous revascularization f 
Figure 3. Allograft survival for all cardiac transplant recipients under- 
going revascularization procedures. 
allograft coronary artery disease is that cardiac surgical sup- 
port for emergency coronary bypass surgery is judiciously 
utilized because of the diffuseness of allograft arteriopathy. 
The cases of left main coronary artery dissection with angio- 
plasty and atherectomy may have been caused by an altered 
takeoff of the left main coronary ostium in the transplanted 
heart or by the left main coronary artery being a diffusely 
diseased, friable vessel. On the basis of this experience with 
predominantly proximal and midvessel disease, coronary re- 
vascularization cannot be recommended as a treatment for 
distal small-vessel disease in cardiac allograft recipients. 
Coronary artery bypass graft surgery. The limited experi- 
ence with coronary artery bypass graft surgery used in the 
treatment of allograft coronary artery disease reflects the 
infrequency of focal proximal and midvessel coronary stenoses 
with suitable distal targets for anastomoses. Although carefully 
selected transplant recipients with significant coronary artery 
disease may benefit from coronary artery bypass urgery in lieu 
of retransplantation, theimmediate procedural outcomes ap- 
pear worse than those after coronary artery bypass reopera- 
tions for severe native atherosclerosis (33). 
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Figure 4. Allograft survival after revascularization procedures: effect 
of distal arteriopathy (DA). 
The reasons for increased perioperative mortality remain 
uncertain. Intraoperative or postoperative pump failure may 
have been caused by diffuse disease of the microcirculation 
despite angiographically inconspicuous distal arteriopathy. 
The microvasculopathy may fail to provide adequate myocar- 
dial perfusion during and after cardiopulmonary b pass. The 
explanation for the perioperative bleeding complications i
undetermined; increased bleeding may have resulted from 
capillary fragility from prolonged steroid use. Myocardial 
infarction, arrhythmias and infection were not associated with 
perioperative mortality in the present study. The fact that the 
center performing the most bypass operations in cardiac 
transplant recipients had no perioperative mortality under- 
scores the importance of operator experience in the treatment 
of this patient cohort, analogous to the institutional learning 
curve for heart transplantation (34). Although preliminary 
information suggests that bypass graft patency before hospital 
discharge and at 6 months is reasonable, the long-term patency 
of internal mammary artery and saphenous vein conduits in 
cardiac transplant patients remains to be determined. 
Distal arteriopathy. In cardiac transplant recipients with 
major epicardial coronary disease warranting coronary revas- 
cularization, the present study indicates that the angiographic 
appearance of distal arteriopathy was predictive of increased 
mortality. This is consistent with clinicopathologic f ndings that 
patients with diffuse narrowing involving both large and small 
vessels were at greater isk for death, myocardial infarction 
and retransplantation than if large- or small-vessel disease 
occurred separately (35). The late outcome of patients with 
discrete lesions suitable for coronary angioplasty was worse if 
concomitant small-vessel disease was present on the preproce- 
dural angiogram. If the cohort of patients treated with atherec- 
tomy and bypass urgery were larger, a similar influence of 
distal arteriopathy on allograft survival would be expected. The 
early outcome of transplant recipients treated with coronary 
artery bypass urgery appears to be adversely affected by anglo- 
graphically evident distal arteriopathy. A larger number of such 
patients will be necessary to confirm these preliminary findings. 
The angiographic presence of distal arteriopathy represents 
the "tip of the iceberg" of a diffuse morphologic and physio- 
logic vasculopathy (36-39). This is not surprising because 
coronary angiography underestimates the presence and sever- 
ity of allograft coronary artery disease (40) as a result of the 
inherent limitations of angiography toprovide only a "lumino- 
gram" (41,42) and the reliance of an adjacent vessel caliber as 
normal (43-45). It is conceivable that angiographic distal 
arteriopathy, a surrogate for severe microvasculopathy, is the 
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rate-limiting step in cardiac allograft survival by the first year 
after heart transplantation. 
In the future more careful scrutiny of the angiogram (46), 
improved intravascular imaging modalities, such as lower 
profile intracoronary ultrasound (47-54) and angioscopic (51) 
catheters, and physiologic assessment of microcirculatory func- 
tion (39,53-62) may lead to improved recognition of allograft 
vasculopathy and, perhaps, prognostication f cardiac allograft 
survival. 
Study limitations. The present study is retrospective, and 
patient selection for therapy was variable. Angiographic visual 
interpretation was by individual center ather than by central 
review utilizing quantitative techniques. However, the study 
was inclusive of all cardiac transplant recipients treated with 
coronary angioplasty, directional atherectomy or bypass ur- 
gery at each medical center. Despite these limitations, the 
present collaborative study represents a unique attempt o 
collect and analyze the results of specific coronary revascular- 
ization procedures in allograft atherosclerosis. 
Conclusions and implications. Coronary revascularization 
may be performed as palliative therapy in suitable cardiac 
transplant recipients. Balloon angioplasty has comparable suc- 
cess but more severe complications than angioplasty of native 
coronary atherosclerosis. Angioplasty appears to have an ac- 
ceptable survival rate in patients in whom there is no angio- 
graphic evidence of distal arteriopathy. However, coronary. 
angioplasty has a limited role when extensive distal arteriopa- 
thy is evident on the angiogram. 
Because of the small number of cardiac transplant recipi- 
ents treated with directional coronary atherectomy and coro- 
nary artery bypass urgery, assessment of these revasculariza- 
tion procedures i limited. 
The angiographic presence of distal arteriopathy is associ- 
ated with decreased allograft survival in patients treated with 
revascularization procedures for epicardial coronary artery 
disease. The presence of angiographic distal arteriopathy 
should be considered a significant factor in patient selection 
for coronary revascularization procedures. In view of the 
increasing success of cardiac transplant operations, a larger 
number of patients with allografl coronary artery disease 
suitable for coronary revascularization can be anticipated. 
We gratefully acknowledge Valentin Fuster, MD, PhD. for review of the 
manuscript. The manuscript was typed by Marilyn Chapman. 
Appendix 
Study Co-Investigators and Participating Institutions 
Baylor College of Medicine, Methodist Hospital, Houston, Texas: Neal S. 
Kleiman, MD, James B. Young, MD, W. Carter Grinstead, MD, Richard W. 
Lowry, MD. Cleveland Clinic Foundation, Cleveland, Ohio: Gustavo Rincon, 
MD, Irving Franco, MD. Johns Hopkins Hospital, Baltimore, Maryland: 
Thomas R. Aversano, MD, Gary D. Walford, MD. Loyola University Medical 
Center, Maywood, Illinois: Maryl R. Johnson, MD, Henry J. Sullivan, MD, Maria 
Rosa Costanzo, MD, Sarah A. Johnson, MD, Ferdinand Leya, MD, Alain 
Heroux, MD, Patrick J. Scanlon, MD, Susan G. Fisher. PhD, Laura Weber, MS, 
A. Arthur Halle IIl, MD. Medical College of Virginia, McGuire Velerans Affairs 
Hospital, Richmond, Virginia: George W. Vetrovec, MD, Michael J. Cowley, 
MD, Michael L. Hess, MD, Andrea Hastillo, MD, Germano DiSciascio, MD, 
Amar Nath, MD, Chauncey C. Crandall, MD, P. K. Mohanty, MD, R. R. Lower, 
MD. Saint Louis University Medical Center, Saint Louis, Missouri: Leslie W. 
Miller, MD, Ubeydullah Deligonul, MD, Morton J. Kern, MD. Stanford 
University School of Medicine, Stanford, California: Sharon A. Hunt, MD, 
Edward A. Stinson, MD, Phillip E. Oyer, MD, PhD, John S. Schroeder, MD, 
Mark Perlroth, MD, Timothy Fisehell, MD, Michael L. Stadius, MD. Tampa 
General Hospital, Tampa, Florida: Mark W. Weston, MD, Deborah Rinde- 
Hoffman, MD. Texas Heart Institute, St. Luke's Episcopal Hospital, Houston, 
Texas: Edward K. Massin, MD, Penny Powers, RN. University of Alabama, 
Birmingham, Alabama: Robert C. Bourge, MD, Gary S. Roubin MD, PhD, 
James K. Kirldin, MD, David C. McGitfin, MD. University of Minnesota, 
Minneapolis, Minnesota: Robert F. Wilson, MD, Spencer H. Kubo, MD, David 
Laxson, MD, Betsy Christensen, RN. University of Ottawa, Ottawa, Ontario, 
Canada: Ross A. Davies, MD, J. F. Marquis, MD, A. Koshal, MD, R. Masters, 
MD, S. Jindal, MD, V. Walley, MD, W. Keon, MD. University of Utah, Salt Lake 
City, Utah: Robert B. Wray, MD, John B. O'Connell, MD, Ronald D. Jenkins, 
MD, Richard Sutton, MD. 
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